vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Spire Global, Inc. (SPIR). Click either name above to swap in a different company.

Spire Global, Inc. is the larger business by last-quarter revenue ($15.8M vs $8.1M, roughly 1.9× Arcellx, Inc.). Spire Global, Inc. runs the higher net margin — -176.6% vs -766.0%, a 589.4% gap on every dollar of revenue. On growth, Spire Global, Inc. posted the faster year-over-year revenue change (-26.9% vs -79.3%). Spire Global, Inc. produced more free cash flow last quarter ($-16.2M vs $-63.9M). Over the past eight quarters, Arcellx, Inc.'s revenue compounded faster (-24.6% CAGR vs -32.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Spire Global, Inc. is a space-to-cloud data and analytics company that specializes in the tracking of global data sets powered by a large constellation of nanosatellites, such as the tracking of maritime, aviation and weather patterns.

ACLX vs SPIR — Head-to-Head

Bigger by revenue
SPIR
SPIR
1.9× larger
SPIR
$15.8M
$8.1M
ACLX
Growing faster (revenue YoY)
SPIR
SPIR
+52.4% gap
SPIR
-26.9%
-79.3%
ACLX
Higher net margin
SPIR
SPIR
589.4% more per $
SPIR
-176.6%
-766.0%
ACLX
More free cash flow
SPIR
SPIR
$47.8M more FCF
SPIR
$-16.2M
$-63.9M
ACLX
Faster 2-yr revenue CAGR
ACLX
ACLX
Annualised
ACLX
-24.6%
-32.6%
SPIR

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
SPIR
SPIR
Revenue
$8.1M
$15.8M
Net Profit
$-62.3M
$-28.0M
Gross Margin
40.2%
Operating Margin
-847.6%
-164.1%
Net Margin
-766.0%
-176.6%
Revenue YoY
-79.3%
-26.9%
Net Profit YoY
-765.1%
42.7%
EPS (diluted)
$-1.13
$-0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
SPIR
SPIR
Q4 25
$15.8M
Q3 25
$12.7M
Q2 25
$19.2M
Q1 25
$8.1M
$23.9M
Q4 24
$15.3M
$21.7M
Q3 24
$26.0M
$28.6M
Q2 24
$27.4M
$25.4M
Q1 24
$39.3M
$34.8M
Net Profit
ACLX
ACLX
SPIR
SPIR
Q4 25
$-28.0M
Q3 25
$-19.7M
Q2 25
$119.6M
Q1 25
$-62.3M
$-20.7M
Q4 24
$-47.1M
$-48.8M
Q3 24
$-25.9M
$-12.5M
Q2 24
$-27.2M
$-16.6M
Q1 24
$-7.2M
$-25.5M
Gross Margin
ACLX
ACLX
SPIR
SPIR
Q4 25
40.2%
Q3 25
36.6%
Q2 25
48.9%
Q1 25
36.8%
Q4 24
32.4%
Q3 24
44.5%
Q2 24
43.0%
Q1 24
26.5%
Operating Margin
ACLX
ACLX
SPIR
SPIR
Q4 25
-164.1%
Q3 25
-166.1%
Q2 25
-122.7%
Q1 25
-847.6%
-106.5%
Q4 24
-348.2%
-144.1%
Q3 24
-129.1%
-48.0%
Q2 24
-127.8%
-48.6%
Q1 24
-40.3%
-34.4%
Net Margin
ACLX
ACLX
SPIR
SPIR
Q4 25
-176.6%
Q3 25
-155.3%
Q2 25
623.4%
Q1 25
-766.0%
-86.5%
Q4 24
-308.4%
-225.2%
Q3 24
-99.4%
-43.7%
Q2 24
-99.3%
-65.2%
Q1 24
-18.3%
-73.3%
EPS (diluted)
ACLX
ACLX
SPIR
SPIR
Q4 25
$-0.85
Q3 25
$-0.61
Q2 25
$3.72
Q1 25
$-1.13
$-0.77
Q4 24
$-0.87
$-1.93
Q3 24
$-0.48
$-0.50
Q2 24
$-0.51
$-0.68
Q1 24
$-0.14
$-1.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
SPIR
SPIR
Cash + ST InvestmentsLiquidity on hand
$543.3M
$81.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$112.9M
Total Assets
$648.1M
$211.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
SPIR
SPIR
Q4 25
$81.8M
Q3 25
$96.8M
Q2 25
$117.6M
Q1 25
$543.3M
$35.9M
Q4 24
$587.4M
$19.2M
Q3 24
$574.3M
$36.6M
Q2 24
$516.7M
$45.8M
Q1 24
$573.9M
$63.7M
Total Debt
ACLX
ACLX
SPIR
SPIR
Q4 25
Q3 25
Q2 25
Q1 25
$103.7M
Q4 24
$103.1M
Q3 24
$4.9M
Q2 24
$4.9M
Q1 24
$123.1M
Stockholders' Equity
ACLX
ACLX
SPIR
SPIR
Q4 25
$112.9M
Q3 25
$133.1M
Q2 25
$149.2M
Q1 25
$416.9M
$3.7M
Q4 24
$454.8M
$-11.7M
Q3 24
$483.0M
$30.8M
Q2 24
$487.2M
$40.3M
Q1 24
$496.6M
$52.5M
Total Assets
ACLX
ACLX
SPIR
SPIR
Q4 25
$211.0M
Q3 25
$224.3M
Q2 25
$239.5M
Q1 25
$648.1M
$208.8M
Q4 24
$711.3M
$193.6M
Q3 24
$764.9M
$224.2M
Q2 24
$734.3M
$230.8M
Q1 24
$779.7M
$252.3M
Debt / Equity
ACLX
ACLX
SPIR
SPIR
Q4 25
Q3 25
Q2 25
Q1 25
27.92×
Q4 24
Q3 24
0.16×
Q2 24
0.12×
Q1 24
2.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
SPIR
SPIR
Operating Cash FlowLast quarter
$-63.1M
$-4.3M
Free Cash FlowOCF − Capex
$-63.9M
$-16.2M
FCF MarginFCF / Revenue
-786.4%
-102.1%
Capex IntensityCapex / Revenue
9.6%
75.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M
$-92.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
SPIR
SPIR
Q4 25
$-4.3M
Q3 25
$-12.0M
Q2 25
$-35.1M
Q1 25
$-63.1M
$-8.4M
Q4 24
$-46.0M
$-19.2M
Q3 24
$30.7M
$14.0M
Q2 24
$-36.2M
$-4.4M
Q1 24
$-31.9M
$-8.8M
Free Cash Flow
ACLX
ACLX
SPIR
SPIR
Q4 25
$-16.2M
Q3 25
$-20.4M
Q2 25
$-38.7M
Q1 25
$-63.9M
$-17.3M
Q4 24
$-47.5M
$-24.3M
Q3 24
$28.4M
$5.1M
Q2 24
$-39.5M
$-9.9M
Q1 24
$-38.3M
$-15.9M
FCF Margin
ACLX
ACLX
SPIR
SPIR
Q4 25
-102.1%
Q3 25
-161.3%
Q2 25
-201.7%
Q1 25
-786.4%
-72.6%
Q4 24
-311.3%
-112.2%
Q3 24
109.2%
17.8%
Q2 24
-144.1%
-39.0%
Q1 24
-97.7%
-45.7%
Capex Intensity
ACLX
ACLX
SPIR
SPIR
Q4 25
75.1%
Q3 25
66.2%
Q2 25
18.8%
Q1 25
9.6%
37.3%
Q4 24
9.8%
23.5%
Q3 24
8.8%
31.2%
Q2 24
11.7%
21.8%
Q1 24
16.4%
20.3%
Cash Conversion
ACLX
ACLX
SPIR
SPIR
Q4 25
Q3 25
Q2 25
-0.29×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons